03:09 PM EST - Cardiol Therapeutics Inc. : Announced that data describing Cardiol's nanotechnology approach to drug delivery were submitted by the Company's international research collaborators and accepted for presentation at the American College of Cardiology's 69th Annual Scientific Session & Expo together with the World Congress of Cardiology, held virtually from March 28-30. Cardiol Therapeutics Inc.
shares T.CRDL are trading down $0.02 at $2.52.
